Abstract
Patent foramen ovale (PFO) is a potential conduit for paradoxical embolization to the systemic atrial circulation of a thrombus originating in the venous system. In a selected group of subjects, the prevalence of deep vein thrombosis (DVT) was assessed. Subjects were identified if they underwent magnetic resonance venography (MRV) pelvis and lower extremity doppler (LE-VDU) for assessment of DVT with PFO. The primary outcome measure was to report the number of patients with paradoxical embolization as their suspected etiology of stroke due to the presence of DVT, which then will be considered as determined stroke. Others with determined stroke diagnosis were reported using Treatment of Acute Stroke Trial (TOAST) criteria. At discharge, those without etiology of their stroke were grouped under embolic stroke of undetermined source (ESUS). We further analyzed the prevalence of DVT by age group, ≤ 60 years vs > 60 years to describe if the prevalence is higher with younger age and to evaluate if higher Risk of Paradoxical Embolism (ROPE) score will have higher number of DVTs compared to lower ROPE scores. Of the 293, 19 (7%) were strokes due to paradoxical embolism. At discharge, determined stroke were 54% vs ESUS were 46%. The overall prevalence of DVT was 19 (7%); MRV-pelvis 13 (4%), and LE-VDU was 9 (3%). No significant difference was noted using both modalities. However, in multivariable regression analysis, a trend suggested an association between pelvic thrombi and high ROPE score as the etiology of stroke; OR 3.56 (0.98, 12.93); p = 0.054. Detection of DVT was not associated with PFO, high ROPE scores or young age. Our data indicate an over-reliance of testing for DVT, particularly MRV pelvis with contrast, in patients with PFO. Clinical studies are needed to identify other factors predictive of DVT in patients with ischemic stroke and PFO.
Similar content being viewed by others
References
Lechat P, Mas JL, Lascault G et al (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148–1152
Webster MWI, Smith HJ, Sharpe DN et al (1988) Patent foramen ovale in young stroke patients. Lancet 332:11–12. https://doi.org/10.1016/S0140-6736(88)92944-3
Cabanes L, Mas JL, Cohen A et al (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age A study using transesophageal echocardiography. Stroke 24(12):1865–1873
de Belder MA, Tourikis L, Leech G, Camm AJ (1992) Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 69:1316–1320. https://doi.org/10.1016/0002-9149(92)91228-V
Di Tullio M, Sacco RL, Gopal A et al (1992) Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 117:461–465. https://doi.org/10.7326/0003-4819-117-6-461
Hausmann D, Mügge A, Becht I, Daniel WG (1992) Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 70:668–672. https://doi.org/10.1016/0002-9149(92)90210-P
Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262–2268. https://doi.org/10.1056/NEJMoa071422
Saver JL (2016) Cryptogenic stroke. N Engl J Med 374:2065–2074. https://doi.org/10.1056/NEJMcp1503946
Hart RG, Diener HC, Coutts SB et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429–438. https://doi.org/10.1016/S1474-4422(13)70310-7
Kent DM, Ruthazer R, Weimar C et al (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619–625. https://doi.org/10.1212/WNL.0b013e3182a08d59
Thaler DE, Ruthazer R, Weimar C et al (2014) Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs. Neurology 83:221–226. https://doi.org/10.1212/WNL.0000000000000589
Kent DM, Thaler DE (2011) The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. https://doi.org/10.1186/1745-6215-12-185
Stöllberger C, Slany J, Schuster I et al (1993) The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 119:461–465. https://doi.org/10.7326/0003-4819-119-6-199309150-00003
Ranoux D, Cohen A, Cabanes L et al (1993) Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 24:31–34. https://doi.org/10.1161/01.STR.24.1.31
Lethen H, Flachskampf FA, Schneider R et al (1997) Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 80:1066–1069. https://doi.org/10.1016/S0002-9149(97)00604-8
Cramer SC, Rordorf G, Maki JH et al (2004) Increased pelvic vein thrombi in cryptogenic stroke: results of the paradoxical emboli from large veins in ischemic stroke (PELVIS) study. Stroke 35:46–50. https://doi.org/10.1161/01.STR.0000106137.42649.AB
Homma S, Sacco RL, Di Tullio MR et al (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 105:2625–2631. https://doi.org/10.1161/01.CIR.0000017498.88393.44
Steiner MM, Di Tullio MR, Rundek T et al (1998) Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29:944–948. https://doi.org/10.1161/01.STR.29.5.944
Author information
Authors and Affiliations
Contributions
SS: study concept and design, acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. SR: study concept and design, acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. KP: study concept and design, acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. TN: acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. HI: acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. AS: analysis and interpretation, critical revision of the manuscript for important intellectual content. LZ: analysis and interpretation, critical revision of the manuscript for important intellectual content. LM: analysis and interpretation, critical revision of the manuscript for important intellectual content. SS: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Samuel, S., Reddy, S.T., Parsha, K.N. et al. Routine surveillance of pelvic and lower extremity deep vein thrombosis in stroke patients with patent foramen ovale. J Thromb Thrombolysis 51, 1150–1156 (2021). https://doi.org/10.1007/s11239-020-02262-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-020-02262-w